Development of triple-negative breast cancer radiosensitive gene signature and validation based on transcriptome analysis

Development of triple-negative breast cancer radiosensitive gene signature and validation based on transcriptome analysis

ID:39777081

大小:623.22 KB

页数:6页

时间:2019-07-11

Development of triple-negative breast cancer radiosensitive gene signature and validation based on transcriptome analysis_第1页
Development of triple-negative breast cancer radiosensitive gene signature and validation based on transcriptome analysis_第2页
Development of triple-negative breast cancer radiosensitive gene signature and validation based on transcriptome analysis_第3页
Development of triple-negative breast cancer radiosensitive gene signature and validation based on transcriptome analysis_第4页
Development of triple-negative breast cancer radiosensitive gene signature and validation based on transcriptome analysis_第5页
资源描述:

《Development of triple-negative breast cancer radiosensitive gene signature and validation based on transcriptome analysis》由会员上传分享,免费在线阅读,更多相关内容在学术论文-天天文库

1、BreastCancerResTreatDOI10.1007/s10549-015-3611-0PRECLINICALSTUDYDevelopmentoftriple-negativebreastcancerradiosensitivegenesignatureandvalidationbasedontranscriptomeanalysis1,31,32,31,3AlimujiangWushou•Yi-ZhouJiang•JingHou•Yi-RongLiu•2,31,3Xiao-MaoGuo•Zhi-MingShaoReceive

2、d:22September2015/Accepted:14October2015ÓSpringerScience+BusinessMediaNewYork2015AbstractTriple-negativebreastcancer(TNBC)isapatients.Twogenesignaturesspecificallyidentifiedaheterogeneousdiseasewithhighestloco-regionalrecur-radiosensitivepopulationthathadanimprovedrecurre

3、nce-renceamongbreastcancersubtypes.Radiotherapyisfreesurvivalinpatientstreatedwithsurgeryradio-indispensableforTNBCloco-regionalcontrol.However,chemotherapy(RadiosensitivepatientsvsradioresistantintrinsicradiosensitivitydifferencesexistinTNBCpatientspatients,forseven-ge

4、neRSGS:P=0.024,HR=0.35,andRTisstillprescribedmainlybasedonconventional95%CI0.14–0.87andforthree-geneRSGS:P=0.035,clinicopathologicfeaturesofpatientswithoutconsideringHR=0.38,95%CI0.15–0.94).Incontrast,therewasnothedifferences.Thepurposeofthepresentstudyistosignificantdif

5、ferenceinoutcomebetweenpredicteddevelopandvalidateaTNBCradiosensitivegenesignatureradiosensitiveandradioresistantpatientsthattreatedwith(RSGS)andtoguidetherapeuticdecisions.Inthisstudy,othertreatmentmodality.RSGSsprovideausefultoolforwecomparedtranscriptomeprofilesof12lo

6、callyrecurrentidentificationofradiosensitive/radioresistantTNBCTNBCsto20non-locallyrecurrentTNBCstreatedwithpatientsandtheycouldleadtoabetterselectionofpatientssurgeryradio-chemotherapyanddevelopedaseven-geneforRTprotocols.RSGSandasimplifiedthree-geneRSGSbyusingpathwayana

7、lysis,univariateCoxproportionalhazardsregressionKeywordsTriple-negativebreastcancerTranscriptomemodelandrank-basedlinearalgorithm.Theywerevali-analysisRadiosensitivegenesignaturedatedbyusingtranscriptomeprofilesof166TNBCBackgroundElectronicsupplementarymaterialTheonlin

8、eversionofthisBreastcancer(BC)isthemostcommoncancerdiagnosedarticle(doi:10.1007/s10549-015-3611-0)containssupp

当前文档最多预览五页,下载文档查看全文

此文档下载收益归作者所有

当前文档最多预览五页,下载文档查看全文
温馨提示:
1. 部分包含数学公式或PPT动画的文件,查看预览时可能会显示错乱或异常,文件下载后无此问题,请放心下载。
2. 本文档由用户上传,版权归属用户,天天文库负责整理代发布。如果您对本文档版权有争议请及时联系客服。
3. 下载前请仔细阅读文档内容,确认文档内容符合您的需求后进行下载,若出现内容与标题不符可向本站投诉处理。
4. 下载文档时可能由于网络波动等原因无法下载或下载错误,付费完成后未能成功下载的用户请联系客服处理。